Sarepta Therapeutics | Efectivo Y Equivalentes



Cash And Equivalent Cambio Fecha
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Agios Pharmaceuticals USD 76.25M 177.48M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Amgen USD 11.97B 2.96B 2024-12
Biogen USD 2.38B 675.8M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Daiichi Sankyo JPY 639.84B 42.31B 2025-03
Eli Lilly USD 3.27B 100.6M 2024-12
Gilead Sciences USD 7.93B 2.06B 2025-03
Incyte USD 2.41B 720.83M 2025-03
Insmed USD 555.03M 93.58M 2024-12
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
Moderna USD 1.93B 283M 2024-12
Neurocrine Biosciences USD 233M 116.1M 2024-12
Pfizer USD 1.04B 49M 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Tectonic Therapeutic USD 141.24M 17.86M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Sarepta Therapeutics Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.